Filing Details
- Accession Number:
- 0001140361-23-032216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-29 16:15:42
- Reporting Period:
- 2023-06-27
- Accepted Time:
- 2023-06-29 16:15:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604464 | Atara Biotherapeutics Inc. | ATRA | Biological Products, (No Disgnostic Substances) (2836) | 460920988 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780060 | Pascal Touchon | C/O Atara Biotherapeutics, Inc. 2380 Conejo Spectrum St, Suite 200 Thousand Oaks CA 91320 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-06-27 | 14,291 | $1.66 | 706,671 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units.
Billionaire Hedge Funds
